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Abstract
Coordination between growth and patterning/differentiation is critical if appropriate final organ structure and size is to be
achieved. Understanding how these two processes are regulated is therefore a fundamental and as yet incompletely
answered question. Here we show through genetic analysis that the phospholipase C-c (PLC-c) encoded by small wing (sl)
acts as such a link between growth and patterning/differentiation by modulating some MAPK outputs once activated by the
insulin pathway; particularly, sl promotes growth and suppresses ectopic differentiation in the developing eye and wing,
allowing cells to attain a normal size and differentiate properly. sl mutants have previously been shown to have a
combination of both growth and patterning/differentiation phenotypes: small wings, ectopic wing veins, and extra R7
photoreceptor cells. We show here that PLC-c activated by the insulin pathway participates broadly and positively during
cell growth modulating EGF pathway activity, whereas in cell differentiation PLC-c activated by the insulin receptor
negatively regulates the EGF pathway. These roles require different SH2 domains of PLC-c, and act via classic PLC-c signaling
and EGF ligand processing. By means of PLC-c, the insulin receptor therefore modulates differentiation as well as growth.
Overall, our results provide evidence that PLC-c acts during development at a time when growth ends and differentiation
begins, and is important for proper coordination of these two processes.
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Introduction
During development, proper coordination of growth, prolifera-
tion,andcellulardifferentiationiscriticalforappropriatefinalorgan
structure and size. These processes involve signal transduction
cascades that determine the spatial and temporal pattern of cellular
instructions. Many of these signaling pathways are activated by
growth factors via receptor tyrosine kinases (RTKs). In vertebrates,
phospholipase C-C (PLC-C) is required by some RTKs to regulate
these cellular processes. PLC-C is an intracellular enzyme activated
by a multistep process; the initial step involves membrane
association via RTKs (or non-receptor tyrosine kinases) through
an SH2 (Src-homology 2) domain in PLC-c with a phosphotyrosine
residue in the intracellular domain of the activated receptor.
Following this binding, PLC-c is phosphorylated by the RTK on
one or more tyrosines and then catalyzes the hydrolysis of the
membrane phospholipid phosphatidylinositol (4,5) bisphosphate
(PIP2), generating two intracellular messengers: inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG). IP3 promotes the
release of Ca
2+ from intracellular stores, via its association with the
inositol triphosphate receptor (IP3R), while DAG, together with
Ca
2+, activates protein kinase C (PKC) [1,2,3,4].
In Drosophila melanogaster, a single PLC-C gene has been
identified, encoded by the locus small wing (sl) [5]. The mRNA is
expressed throughout development, with overall expression
highest during embryogenesis [6]. Surprisingly, given this early
expression, a large fraction of homozygotes reach adulthood;
homozygous sl null mutants are recovered, and are viable and
fertile. Yet, sl homozygotes do have developmental defects: their
eyes have a mildly rough phenotype, due to some ommatidia
containing one or more extra R7 photoreceptor cells, and their
wings are smaller than wild type and contain patches of ectopic
veins [5]. These phenotypes indicate that Sl is involved in
regulating differentiation of R7 photoreceptor cells and wing veins,
as well as growth control in the wing.
Genetic experiments suggest that the extra R7 photoreceptor
phenotype results from over activation of the MAPK cascade,
showing that Sl is a negative regulator of this pathway during
photoreceptor development [5]. sl was also identified in a cell-
based RNAi screen for loss-of-function phenotypes that inhibit
endoplasmic reticulum (ER) accumulation of processed Spitz (Spi),
which is an EGF receptor ligand [7]. This suggests that the sl-
encoded PLC-c participates in a Spi retention mechanism in the
ER. Genetic rescue experiments indicate that Sl is required
specifically in cells processing the ligand (a non-cell autonomous
effect), as demonstrated by the rescuing capacity in sl mutant flies
of wild type Sl expression in R8 photoreceptor cells only [7].
Taken together, these results suggest that Sl inhibits the MAPK
pathway through controlled retention of Spi in the ER of R8 cells
in developing compound eyes.
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.TNevertheless, other questions remain. What is the mechanism
by which Sl regulates these different processes (growth, differen-
tiation), and how is Sl itself activated? Do other RTKs activate Sl,
as is the case for PLC-c in vertebrates? Besides the EGF receptor,
an interesting additional RTK candidate for Sl activation is the
insulin receptor, because the insulin pathway regulates growth and
cellular proliferation in all tissues in Drosophila [8]. Most notably,
this pathway was recently shown to be involved in controlling the
timing of differentiation by modulating EGF/MAPK target genes
in developing photoreceptors [9].
Here, we show that Sl stimulates growth. We use the wing to
show through genetic experiments that together with the insulin
and EGF/MAPK pathways and in a manner dependent on
components downstream of Sl such as the IP3R and Pkc53E, Sl
stimulates cellular growth. Also, in the developing wing and eye, Sl
activated by the insulin receptor inhibits MAPK signaling and thus
cellular differentiation in a manner again dependent on PLC-c
signaling downstream components, such as the IP3R. We also
show that PLC-c genetically interacts with Star and Rhomboid,
suggesting modulation of the processing of the EGF ligand Spitz as
an avenue of Sl function in all these different phenotypes.
Finally, we also show that the C-SH2 and N-SH2 domains
individually are not required for cellular growth, whereas only the
N-SH2 domain is required for patterning/differentiation.
Results
Sl modulates cellular growth in the wing
Wings from sl
1 and sl
2 mutants were previously shown to be
reduced in length by about 20% [5]; although these are not null
alleles, they are strong hypomorphs. We compared wild-type and
sl mutant wings and found that the area of the wing blade is also
reduced by 20% (Fig. 1A, B, C). To determine whether this
phenotype results from a reduction in growth or cellular
proliferation, we determined cell density in an area between veins
3 and 4 in the wing (Fig. 1A and 1B). Mutant wings showed
significantly higher cell density than wild-type wings (mean of 8653
and 7106 cells/mm
2, respectively; Fig. 1A’, 1B’ and 1D),
indicating that the mutant wing blade cells are 21% smaller than
wild-type. This means that the reduced area of the wing can be
fully explained by a reduction in cell size. Consistent with this
model, we found that the number of cells in wild-type and sl
mutant wings is not significantly different (Fig. 1E). This
demonstrates that Sl normally acts to stimulate cell growth in
the wing, but does not affect cell proliferation in this tissue.
To determine how Sl stimulates cell growth, we examined the
effects of reductions in gene dosage in the EGF/MAPK and
insulin signaling pathways on the size of sl mutant wings, since
both the MAPK [10] and insulin pathways [8] have been shown to
regulate growth in the wing. The EGFR has multiple ligands:
Spitz (Spi) and Vein (Vn) are activating ligands, whereas Argos
(Aos) is inhibitory. Once activated, the EGFR binds to a
cytoplasmic scaffold protein, Daughter of sevenless (Dos), and to
an adaptor protein, Downstream of receptor kinase (Drk), which
leads to the membrane translocation of the guanine nucleotide
exchange factor Son of sevenless (Sos). There, Sos favors exchange
of bound GDP for GTP in Ras85D, and that, in turn, leads to
activation of the MAPKKK Pole hole (Phl; also known as Raf1),
which in turn activates the Downstream of raf1 (Dsor1) MAPKK;
activated Dsor1 then activates Rolled (Rl), the Drosophila MAPK
[10]. All mutant sl
2 flies heterozygous for mutations in MAPK
pathway components tested have a small but significant further
reduction in the area of the wing blade compared to sl
2 mutants
(Fig. 2A).
In the insulin pathway, the activated insulin receptor (Inr) binds
to the cytoplasmic substrate Chico (a Drosophila homolog of IRS),
which leads to the activation of the lipid kinase phosphoinositide 3-
kinase (PI3K) and, further downstream, the ser/thr kinase protein
kinase B (PKB, also referred to as Akt1) [11]. Mutant sl
2 flies
heterozygous for mutations in Inr and Dp110 (the catalytic subunit
of PI3K) showed a similar effect to mutations in genes of the
MAPK pathway (Fig. 2B). In contrast, sl
2 flies with a mutation in
PKB have bigger wings than sl
2 alone, suggesting a negative
feedback loop on pathways stimulating cellular growth in this
context. Taken together, these data indicate that Sl normally
participates with the EGF/MAPK and insulin pathways as a
positive mediator of cell growth in the wing.
PLC-c catalytic activity generates IP3 and DAG by PIP2
hydrolysis, leading to modulation of Ca
2+ release by IP3 receptors
and PKC activation. In order to study PKC involvement, we
characterized a mutation in one of the fly homologs of PKC,
PKC53E. PKC53E mutants are homozygous viable and fertile, yet
have a reduction in wing size of 11.5%, similar to sl mutants; by
contrast, PKC53E heterozygotes have wild-type wings (Fig. S1A).
We therefore tested whether the PKC53E growth phenotype can
be tied to known PLC second messengers. In an sl mutant
background, reduced gene dosage of IP3R or PKC53E produced
further reductions in wing size (Fig. 2C). In the same sl mutant
background, heterozygosity for a mutation in Rack1, a gene that
encodes an scaffold protein for various signaling molecules
including PKC [12], generated a similar effect (Fig. 2C). These
results are consistent with the idea that the cell growth defect in sl
mutants operates via the classic PLC second messengers IP3 and
DAG, with a concomitant effect on PKC.
Further downstream, we sought to investigate whether process-
ing of Spitz is required for sl dependent wing growth, as Sl has
been shown to participate in a Spi retention mechanism in the ER
during eye development [7]. To do so, we evaluated the function
of rhomboid (rho), which encodes a Golgi membrane protease that
cleaves the inactive, membrane bound Spi precursor to generate
mature, secretable Spi [13]; Star (S), which encodes a type II
transmembrane protein involved in trafficking Spi from the ER to
the Golgi [13,14], and spi itself. Flies heterozygous for mutations in
these three genes in an sl
2 mutant background indeed showed
greater reductions in wing size than solely sl
2 mutant flies (Fig. 2).
Heterozygosity for spi in an sl mutant background gave the biggest
reduction of all tested interactions: wings were reduced a further
65% assuming sl
2 reduction as 100%, while heterozygosity for
IP3R, PKC53E, Rack1, rho and S gave reductions between 10 and
45%. This suggests that Sl regulates cellular growth in the wing by
positively modulating Spi processing. Heterozygosity for aos and vn
also gave further reductions in wing size, indicating their
involvement in modulating MAPK pathway activity by sl (Fig. 2A).
We repeated some of these genetic interactions with the
molecular null allele sl
9. We found that mutations in the MAPK
and insulin pathways, as well as in the IP3R, do not modify the
wing size of sl
9 mutant flies (Fig. 2D). As sl
9 is a molecular null, this
means that at the time of Sl function, the MAPK/insulin pathways
regulate wing size solely through Sl-dependent avenues.
Sl has a broad role in cell growth
Since Sl normally acts to stimulate cellular growth in the wing,
we wondered whether it plays a similar role in other tissues. As sl
mutant eyes have extra R7 photoreceptor cells, indicative of sl
function there [5], we sought to investigate whether growth
phenotypes are present in this structure as well. We found that
indeed, the area of the eye in sl
9 homozygotes is reduced by about
8% compared to wild-type controls (p,0.002; Figs. 3A, B, C).
Fly PLC-y Regulates Growth and Differentiation
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number of ommatidia, as we found a mean of 765 ommatidia in
wild-type controls compared to only 698 in sl
9 homozygous eyes
(p,0.0001; Fig. 3D).
Given that sl mutants show smaller cells in the wing, we also
tested whether there might also be a cell size change in the eye,
using the FLP-FRT system to generate mutant clones in otherwise
wild-type tissue. Because loss of sl results in the recruitment of
additional R7 photoreceptors [5], we compared the combined
area of the rhabdomeres in R1–R6 photoreceptor cells between
adjacent sl
9/+ and sl
9 mutant patches. We found that this area was
reduced in mutant patches by an average of 15.2% compared to
adjacent sl
9/+ patches in the same section (Figs. 3E and 3F).
If Sl is involved more globally in growth control we might
expect to see a change in the overall size of the fly, as observed for
mutations in the insulin signaling pathway [8]. One way in which
this might be manifest is in the animal’s mass. We compared two-
day-old sl
9 homozygous females with sibling sl
9 heterozygotes and
found the mutants are about 8% lighter: 1.2960.019 mg
compared to 1.4160.017 mg. This difference is highly significant
(p,0.001; n=70 per genotype; mean 6 SEM). We also evaluated
pupae using the same genotypes, measuring both pupal length
Figure 1. Wing phenotype of sl
2 mutants compared to ORR (Oregon R) controls. Only male flies were used in this and subsequent figures
unless otherwise noted. (A) Wild type wing. (A’) shows a higher magnification of boxed area in (A), illustrating the wing region used to determine cell
density. (B) sl
2 mutant wing. (B’) shows an amplification of boxed area in (B), used to determine cell density. (C) Histogram showing the reduced
mutant sl
2 wings area. n=100. (D) Histogram showing an increase in cell density in sl mutant wings. n=100. (E) Histogram showing the averages of
total number of cells of complete wing surfaces. n=5. sl
2 and ORR do not differ significantly. *p,0.001; error bars represent SEM.
doi:10.1371/journal.pone.0028067.g001
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significant differences (3.1660.01 mm for sl
9 homozygotes to
3.1460.009 mm for sl
9 heterozygotes measuring pupal longest
axis, and 1.44660.012 mg for sl
9 homozygotes, to
1.46460.012 mg for sl
9 heterozygotes. n=73 for sl
9 homozygotes,
and n=79 for sl
9 heterozygotes; mean 6 SEM). These analyses
show that Sl plays a more general role in the promotion of cell
growth, beyond the one classically described in the wing.
Insulin receptor via Sl inhibits wing vein differentiation
sl
2 mutant flies sometimes show small ectopic wing veins,
indicating an excess of cellular differentiation [5]. Vein
differentiation in the wing is regulated by various pathways,
including the EGF/MAPK, amongst others [review in 17,18].
We found that reductions in gene dosage of most MAPK
pathway genes tested partially rescued the ectopic vein phenotype
of sl
2 mutant wings, indicating that the ectopic veins are a result
of over activation of MAPK signaling, the exceptions being aos
and spi. Consistent with its role as an EGFR inhibitory ligand,
heterozygosity for aos significantly augmented the ectopic vein sl
phenotype, strongly implying Aos in the regulation of vein
differentiation. In contrast, heterozygosity for spi had no
significant effect, indicating that for vein differentiation Vn,
rather than Spi, is critical (Fig. 4A).
sl
2 mutant flies heterozygous for mutations in the insulin
pathway show no consistent change in the ectopic veins phenotype
of sl
2 wings; one shows a significant increase (InR), one shows a
significant decrease (Dp110) and two others (chico and PKB) are
unchanged (Fig. 4B). Given that the sl ectopic vein phenotype is
exacerbated in a heterozygous InR background, this argues that
the sl-encoded PLC-c requires the insulin receptor to regulate cell
differentiation in the wing, but the pathway downstream of the
receptor may not be the standard one described in other contexts.
To explore further the possibility of a role for insulin signaling in
wing vein formation we examined viable heteroallelic combina-
tions of both InR and PKB (InR
E19/3T5 and PKB
1/3). In each case
we observed low percentages of wings with small ectopic vein-like
patches (12.7%, n=79 for InR and 8% n=87 for PKB),
confirming their participation in vein differentiation (Fig. 4C
and 4D).
We wondered whether the excess vein differentiation in the sl
mutants occurs via the canonical downstream PLC effectors, so we
determined the effect of changes in dosage of some of these.
Heterozygosity for mutations in the IP3R and Rack1 significantly
increased the ectopic vein area in sl
2 mutant wings; in addition, we
observed a dramatic increase in the vein phenotype when the
dosage of PKC53E was reduced in an sl
2 mutant background
(Fig. 4E). This is consistent with a previous report describing
Figure 2. Reduced gene dosage of MAPK and insulin pathway genes on sl mutant wings. Heterozygous mutant conditions for EGF/MAPK
(A) and insulin (B) signaling genes, and genes downstream of Sl (C) change the sl
2 mutant wing size. Histogram in (D) shows the effects on sl
9 mutant
wing size of heterozygosity for genes of the insulin and MAPK pathways and of the IP3R. n=100 in all cases, * p,0.001; error bars represent SEM. In
this and subsequent figures showing genetic interactions, tests were done with hemizygous sl
2 or sl
9 males and heterozygous or wild type for the
genes tested unless otherwise noted.
doi:10.1371/journal.pone.0028067.g002
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PKC53E regulates vein differentiation in the wing [19]. In
agreement with this finding, we found that flies homozygous for a
hypomorphic allele of PKC53E also show ectopic veins (Fig. S1B),
even if surveyed in an sl
+ background. This argues that function of
this PKC homolog, PKC53E, is particularly important for vein
formation.
As mentioned earlier, the mechanism by which Sl affects R7
photoreceptor differentiation is proposed to be via its involvement
in ER retention of the EGF ligand Spitz, in a pathway that also
involves Rho and Star [7]. Does the same mechanism operate in
the wing? We found that heterozygosity for mutant alleles of rho
and S, but not spi, increased the vein phenotype of sl
2 mutants
(Fig. 4E), suggesting a Spi-independent role for Rhomboid-1 and
Star in modulation of vein differentiation, perhaps by their
involvement in the processing of a MAPK pathway ligand other
than Spi, such as Keren.
We looked at some of the same interactions with the null allele
sl
9 and found that mutations in the MAPK and insulin pathways in
general, as well as in the IP3R, affect the extent of ectopic vein
territory in sl
9 mutant flies in a similar fashion to that seen in sl
2
mutants (Fig. S2). Because a further increase in severity of the wing
vein phenotype can be seen in sl
9, this indicates that Sl is not the
only avenue of vein differentiation modulation by insulin signaling.
IP3R activity is also required independent of Sl, most likely
regulated by cytoplasmic calcium concentrations as the IP3Ri s
known to be regulated by calcium [20], and this could account for
the exacerbation of the ectopic vein phenotype in an sl
9 null
mutant background. Taken together, these results confirm a
previously unrecognized role for insulin receptor signaling in
differentiation and imply that there are both Sl-dependent and Sl-
independent ways of regulating vein differentiation by insulin
signaling in the wing.
Insulin receptor participates in R7 photoreceptor
differentiation via Sl
sl mutant flies have extra R7 photoreceptors in the eye,
indicating that Sl normally inhibits cellular differentiation of this
cell type [5]. A reduction in gene dosage of components of the
MAPK pathway partially rescues the extra R7 photoreceptor
Figure 3. Sl affects eye size. Images in (A, B) are SEMs of control (A; Canton S) and (B) sl
9 homozygote female flies. Notice mild
roughness of sl
9 mutant eye; red bar in A is 100 mm. (C) Average areas of whole eyes of control (Canton S) and sl
9 homozygotes. Areas are expressed
in mm
2; n=18 for Canton S and 16 for sl
9. (D) Average number of ommatidia in eyes of Canton S and sl
9 homozygotes (n=13 for both Canton S and
sl
9). Digitized images of eyes were used for measurements in (C) and (D), and in both cases differences are significant at p,0.002 (C) and p,0.0001
(D). (E) Plastic section through an eye containing a yws l
9 homozygous clone, marked by the absence of red pigment surrounding the ommatidia; a
black line indicates the approximate edge of the mutant clone. Three ommatidia showing the extra R7 photoreceptors characteristic of sl mutants are
indicated by arrows. (F) A comparison of sl
+ and sl mutant tissue in nine heads (each pair of bars represents data from an individual head; dark grey
bars represent wild-type cells, light grey bars represent cells in mutant patches). The area of R1–R6 rhabdomeres was determined in three to fifteen
pairs of nearby ommatidia in each head, each pair consisting of one sl
+ (w
+) ommatidium and one sl
9 homozygous (w
-) ommatidium.
doi:10.1371/journal.pone.0028067.g003
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that the differentiation defect, like the ectopic vein phenotype, is
due to pathway over activation. The sole exception, of the genes
tested, is aos. As expected, and consistent with its role as an EGFR
inhibitory ligand, heterozygosity for aos in an sl mutant
background resulted in a dramatic increase in the sl mutant extra
R7 phenotype. Male sl
2; aos
D7/+ eyes also have noticeably
increased roughness (Fig. S3).
We examined next whether the insulin pathway is also involved
in this process by analyzing the effect of heterozygous mutations in
this pathway on the number of ommatidia with extra R7 cells in sl
2
mutant eyes. Similar to our findings with the ectopic wing vein
phenotype, only heterozygosity for mutations in the insulin
receptor itself showed a significant increase in the photoreceptor
phenotype (Fig. 6B and 6C). The average number of R7 cells per
ommatidium rose dramatically: from 1.2560.003 in sl
2 males to
1.8960.36 (n=4–6 eyes, p,0.002) for sibling sl
2 males with a
copy of InR
GC25. We found the same result with another
hypomorphic allele of PLC-c: sl
1 (Fig. S4A). The average number
of R7 cells per ommatidium rose from 1.1060.037 in sl
1 males to
1.5860.038 (n=5–7 eyes, p,0.002) for sibling sl
1 males with a
copy of InR
GC25. By contrast, in an sl
9 background, the InR
mutation did not increase the severity of the R7 phenotype (Fig.
S4B), but given that sl
9 is a molecular null, this result is expected if
Sl is the only avenue of modulation for the insulin receptor in the
eye. This contrasts with the vein differentiation results, suggesting
different modes of activity for Sl in these processes. We also found
that reduced dosage of chico, Dp110 and PKB significantly
decreased the extra R7 phenotype of sl
2 mutants (Fig. 6C).
Heterozygosity for a mutation in the IP3R in an sl
2 mutant
background showed an increase in the number of ommatidia with
extra R7 cells (Fig. 6F), and in the number of R7 cells per
ommatidium (Fig. 6E) (from 1.2560.003 in sl
2 males, to
1.7660.11 in sibling sl
2 males with a copy of IP3R
B4,n = 5 ,
p,0.001). A similar effect was observed for the same IP3R
mutation in an sl
9 mutant background (Fig. S4B), indicating that
the IP3R regulates R7 differentiation in Sl-dependent and Sl-
independent ways, as is the case for ectopic vein differentiation.
Mutant sl
2 flies heterozygous for a mutation in PKC53E also
showed a significant increase in the extra R7 photoreceptor
phenotype (Fig. 6F). However, flies homozygous for a PKC53E
mutation alone showed ,1% of ommatidia with extra R7 cells
(Fig. S1C); in contrast, about 50% of these mutant flies showed
ectopic veins in the wing, indicating that this protein has an
important role in the regulation of vein differentiation but not in
R7 differentiation. In agreement with this, heterozygosity for
Figure 4. Reduced gene dosage of MAPK and insulin pathway genes on sl
2 ectopic wing veins. Shown are effects of heterozygous mutant
conditions for EGF/MAPK (A) and insulin (B) pathway genes on the sl
2 ectopic vein phenotype. (C, D) show wings of heteroallelic mutant InR
E19/3T5 (C)
and PKB
1/3 (D) flies with small ectopic vein-like patches. (C’) and (D’) show close-ups of boxed areas in (C) and (D), respectively. Arrows point to vein-
like material present. As heterozygotes, neither InR nor PKB show ectopic wing vein-like material. (E) Effects of heterozygosity for IP3R
B4,
PKC53E
EY14093, Rack1
EE, rho
ve-1 and S
2 on the extent of sl
2 ectopic wing veins. n=100. *p,0.001; error bars represent SEM.
doi:10.1371/journal.pone.0028067.g004
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2 mutant
background (Fig. 6F).
We found that heterozygosity for rho and spi mutant alleles
produced a significant decrease in the extra R7 phenotype of sl
2
mutants, from 1.2560.003 in sl
2 to 1.0960.019 for sl
2 heterozy-
gous for rho and to 1.1360.015 for sl
2 heterozygous for spi (Fig. 6F
and 5C show these reductions as percentages). S mutations have a
dominant phenotype in the eye; one of these is a discrete loss of R7
cells in S
2 (4.9760.42 percent of ommatidia without R7 cells or
0.9560.004 R7 cells per ommatidium). We examined whether this
dominant phenotype could be modified in an sl mutant
background, and found that in S
2 heterozygotes the R7 phenotype
is not changed if also mutant for sl
2 (Fig. S5).
Overall, these data are consistent with a role for Sl in a Spi
retention mechanism in the ER in photoreceptor cells [7],
suggesting that Sl normally inhibits R7 differentiation by
negatively modulating processing of Spi, which in turn modifies
the strength of MAPK signaling. In summary, these results suggest
that Sl, activated by the insulin receptor, modulates photoreceptor
differentiation via the IP3R and PKC53E through negative
regulation of the EGF/MAPK pathway ligands.
Role of SH2 domains in Sl function
In order to study in more detail the relationship between Sl and
receptor tyrosine kinases (insulin and EGF receptors) in the wing
and eye, we examined the role of the Sl SH2 domains, which are
known to be involved in the binding of PLC-c to RTKs in
vertebrates. We generated sl genomic rescue constructs with either
the N- or C-terminal SH2 domains carrying mutations that disable
their function in other systems (Fig. 7A) [21,22]. Transgenic flies
containing a wild type sl construct (X10), C-SH2 mutant (C-SH2)
or N-SH2 mutant (N-SH2) constructs rescued the wing size defect
in sl
2 mutants (Fig. 7B). However, while the wild type and C-SH2
mutant constructs rescued the ectopic veins and extra R7
photoreceptors phenotype, the N-SH2 mutant construct did not
(Figs. 7C and 7D). These results are consistent with experiments in
mammals, in which the two SH2 domains have differential roles in
the binding and activation of PLC-c by RTKs[21].
Discussion
Sl modulates cellular growth in the wing
We show, by measuring cell density, that sl mutant wings have a
reduction in cell growth but not cell proliferation. This defect is
qualitatively similar to mutations in MAPK signaling; cells with
homozygous mutations for members of this pathway have higher
cell densities, suggesting smaller cells [10]. Of the several signaling
pathways known to be involved in Drosophila wing growth [23],
only the MAPK and insulin pathways are triggered by tyrosine
kinase receptors that are likely to activate Sl. Our results show that
indeed both pathways are genetically linked to Sl in promoting cell
growth, probably acting in a concerted fashion; further molecular
studies will be required to reveal the molecular mechanisms and
Figure 5. Reduced gene dosage of MAPK pathway genes on sl
2 R7 phenotype. Tangential sections of the distal part of eyes from sl
2 (A) and
sl
2 heterozygous for Drk
e0A (B) flies, stained with toluidine blue. The arrows indicate extra R7 cells. (C) Histogram showing the effect of heterozygosity
for mutations in genes of the MAPK pathway on extra R7 cells in sl
2 mutants. n=5 eyes each with #150 ommatidia per eye. *p,0.001; error bars
represent SEM.
doi:10.1371/journal.pone.0028067.g005
Fly PLC-y Regulates Growth and Differentiation
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e28067physical interactions that allow this link. Sl signaling thus provides
a means for coordinating growth by forming a regulatory link
between the MAPK and insulin pathways. In this scenario, Sl
activated by the insulin pathway would function by modulating
MAPK output; that is to say, to reduce somewhat the levels of
MAPK activity, but not to stop it, as no MAPK activity leads to no
growth and cell death [10,24], and too much MAPK activity leads
to ectopic differentiation and reduced growth (our results, and [7])
(Fig. 8A).
Sl modulates cellular growth in the eye
We found that Sl regulates cellular growth in the eye. Whole
eyes are smaller, and the difference in size can be largely explained
by the presence of fewer ommatidia. This means that sl mutant
eyes very likely contain fewer cells, despite the fact that some
ommatidia sport one or two extra R7 cells, as the number of cells
missing due to reduced numbers of ommatidia is bigger than the
number of extra R7 cells present. This suggests either reduced
proliferation or increased cell death in differentiating sl mutant
eyes, and is different from the growth defect found in wings, yet
consistent with a moderate requirement of MAPK output to
promote growth and cellular survival.
We also surveyed whether mutant eye cells are smaller, in a
situation where a direct comparison could be made between
mutant and wild-type cells. By studying sl loss-of-function clones in
the eye, we determined that sl mutant cells are smaller than
neighboring wild-type cells. This growth defect is similar to that
seen in wings, suggesting a more general growth regulation by Sl in
different tissues, albeit in a situation where competition between
cells of different genotype does take place.
Sl also has growth effects beyond the eye and wing
Not only is cell size reduced to a similar extent in both the eye
and wing of sl homozygotes; we found that the adult animal as a
Figure 6. Reduced gene dosage of insulin pathway and downstream components on the sl
2 extra R7 phenotype. Tangential sections of
the distal part of eyes from sl
2 (A) and sl
2 heterozygous for InR
E19 (B) flies, stained with toluidine blue. Arrows indicate extra R7 cells. (C) Histogram
showing the effect of heterozygosity for mutations in genes of the insulin pathway on the percentage of ommatidia with extra R7 cells in sl
2 mutants.
n=5 eyes each with #150 ommatidia per eye. *p,0.001; error bars represent SEM. Tangential sections of the distal part of eyes from sl
2 (D) and sl
2
heterozygous for Ip3R
B4(E) flies, stained with toluidine blue. Arrow indicates ectopic R7 cells. (F) Histogram showing the effect of heterozygosity for
Ip3R
B4, PKC53E
EY14093, Rack1
EE and rho
ve-1 on the percentage of ommatidia with extra R7 cells in sl
2 mutants. n=5 eyes each with #150 ommatidia per
eye. *p,0.001; error bars represent SEM.
doi:10.1371/journal.pone.0028067.g006
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of a similar magnitude to the reduction in cell size in the eye
(15%) and wing (20%), the most parsimonious explanation for
this change in mass is that the same Sl functions found in the eye
and wing are required more generally throughout the animal,
suggesting that cell size may be reduced in many tissues.
However, we found that the reduced growth observed in the
adult was not reflected by a reduction in length of sl mutant
pupae. This is in contrast to mutations of other genes involved in
growth control, such as the neurofibromin 1 gene [15,16], which
shows a significant reduction in pupal length. This might be
because sl has a relatively small effect on growth, varying between
5% and 20% in different contexts, so our sample may not have
been large enough to observe a small change in mean length.
Given that Sl does not appear to affect the length of appendages
other than the wing (J.Thackeray, unpublished data), it may be
that there are other compensatory effects resulting from lost Sl
function that maintain the pupal case at an approximately wild-
type length.
Another complementary explanation for the reduction in adult
mass is via a role for Sl on nutrient sensing. As Sl is clearly
involved in insulin signaling, and as insulin is required for
integrating nutrient sensation in Drosophila [25], the effect on mass
might be a combination of impacts on both growth signaling and
nutrient sensing.
We propose that the overall role for Sl is to act as a pro-growth
agent, allowing cells and tissues to attain normal numbers and
sizes. This is achieved by dampening MAPK output in growth
control in a non-cell autonomous manner, by restricting
processing of EGFR ligand(s), as shown previously for R7 cell
differentiation [7]. Since both the MAPK and insulin pathways
initially act to favor proliferation and growth, we propose that Sl
functions here under insulin pathway control, allowing growth to
continue, preventing ectopic differentiation (Fig. 8A). There are
several ways in which it could do so: by directing activated MAPK
to a different cellular compartment (cytosolic versus nuclear [26])
or by controlling overall strength and duration of signaling [27],
examples of which have been shown to elicit such changes in
developing wing cells in both Drosophila and PC12 cells.
Sl inhibits wing vein differentiation
As opposed to promoting wing cell growth, Sl inhibits wing vein
formation. Positioning and differentiation of provein and intervein
territories in the wing are determined by at least five different
signaling pathways: Hedgehog (Hh), Decapentaplegic (Dpp, a
bone morphogenetic protein homolog), epidermal growth factor
(EGF)/MAPK, Wingless (Wg; Wnt), and Notch [17]. Genes of the
EGF/MAPK signaling pathway are expressed at higher levels in
provein territories; activation of this pathway is required for
provein to vein differentiation [28]. As mentioned above, sl mutant
Figure 7. Expression of wild type (X10) and mutant sl constructs in a mutant sl
2 background. (A) Schematic representation of mutations
in the SH2 domains of PLC-c. (B) Histogram showing the effect of expression of sl constructs on sl
2 wing size. n=100. *p,0.001; error bars represent
SEM. (C) Histogram showing the effect of expression of sl constructs on ectopic wing veins of sl
2 mutant flies. n=100. *p,0.001; error bars represent
SEM. (D) Histogram showing the effect of expression of sl constructs on extra R7 cells in sl
2 mutant eyes. n=5 eyes each with #150 ommatidia per
eye. *p,0.001; error bars represent SEM.
doi:10.1371/journal.pone.0028067.g007
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PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e28067flies show ectopic vein patches indicating an excess of vein
differentiation. Here we show that heterozygosity for MAPK
pathway genes, in a sensitized sl mutant background, caused a
partial rescue of the sl vein differentiation defect, indicating that
the sl phenotype is a consequence of MAPK over activation. In
this case, Sl acts as a negative regulator of MAPK signaling.
The dual roles played by Sl in the wing via the same MAPK
pathway – promotion of growth and subsequently, promotion of
differentiation –– can be explained if Sl is helping to establish
appropriate MAPK activity at each developmental stage. Alter-
natively, given that growth and differentiation tend to be
temporally separated [29], these distinct effects probably occur
in cells that are at different stages of development and therefore
different effector molecules are likely to be present. Furthermore,
these results also suggest that PI3K (of which Dp110 is a
component), which inhibits Sl ectopic veins, might have a negative
role in regulation of PLC-c (figure 4B), in addition to the positive
effect described in mammals [30]. Given that PI3K and Sl
compete for the same substrate, the interaction we see between
them in the wing might due to an altered ratio of phosphatidyl
bisphosphates to phosphatidyl trisphosphates available at the
membrane near the activated RTK.
Insulin receptor involvement in wing vein differentiation
Strikingly, there appears to be no role for the insulin pathway in
vein differentiation, save for the insulin receptor itself; however,
this finding is consistent with studies showing that the insulin
pathway as a whole is generally not involved in differentiation [8].
Despite this, we found that mutations in the insulin receptor
generate dramatic increases in ectopic wing veins in sl mutant
backgrounds. These results clearly indicate a requirement for the
insulin receptor in Sl-mediated inhibition of vein differentiation,
suggesting that Sl is activated by this receptor. In mammalian cells
there is some evidence for this type of association [31], but this is
the first evidence of such an interaction in Drosophila. Such an
interaction might be direct via one of the Sl SH2 domains, or
indirectly through an adaptor such as Lnk.
The insulin receptor inhibits R7 photoreceptor
differentiation via Sl
Photoreceptor differentiation begins in the third larval instar
with the passage of the morphogenetic furrow across the eye
imaginal disc. The R8 photoreceptor differentiates first, nucleating
developing ommatidia without requiring EGF/MAPK activation.
In contrast, the R7 photoreceptor is the last to differentiate and
requires MAPK-mediated activation involving both the EGF and
Sevenless receptors [32,33]. The presence of extra R7 photore-
ceptors in sl mutant eyes indicates that Sl normally inhibits R7
differentiation, resulting in only one R7 cell per ommatidium [5].
We confirmed that this phenotype is a consequence of over
activation of MAPK signaling, because heterozygous mutant
conditions for genes in this pathway almost completely rescue the
sl eye defect [5,7]. We also found a role for insulin signaling in R7
development, but as in vein differentiation, only mutations for the
insulin receptor itself augmented the sl phenotype in an sl mutant
background. Thus, in this instance as well, the insulin receptor
appears to activate Sl to enable it to regulate R7 differentiation.
This eye phenotype therefore follows the same logic as vein
differentiation, constituting another case of close association
between the insulin receptor and Sl. As Sl does not show the
same interaction with Chico as with InR, activation of Sl via InR
may require either direct binding of Sl to InR or another insulin
pathway adaptor molecule, such as Lnk [34]. It will be of interest
to see if there is physical interaction between Sl and InR or Lnk in
this context. Taken together, these results are consistent with Sl
acting to reduce MAPK output to prevent ectopic differentiation
(Fig. 8B).
Sl mode of action
A central function of all phospholipase C enzymes is hydrolysis
of PIP2. In this study we showed that regulation of growth and
differentiation by Sl must depend on PIP2 hydrolysis to some
extent, because of the interaction between sl and mutations in
IP3R, PKC53E and Rack1. Also, by means of genetic tests, we found
that Sl requires the Spi processing machinery (S, Rho) to regulate
growth and differentiation. It has previously been shown that Sl
acts on Spi processing during R7 differentiation, by favoring Spi
retention in the endoplasmic reticulum [7]. In order to rationalize
Sl function in all the phenotypes studied, we reason that by
inhibiting Spitz processing, Sl could delay initiation of differen-
tiation, allowing still undifferentiated cells to grow and attain a
normal size before the onset of differentiation. Sl modes of action
in growth and differentiation may be different; sl alleles affecting
the wing but not the eye is strong evidence for this assertion [35].
In general, during growth, Sl activated by the insulin pathway
acts as a liaison regulating MAPK pathway ligand processing, to
promote MAPK activation to a level permitting growth. In
agreement with a well-characterized case in mammalian cells [27],
we propose that this level of activity of MAPK is different from the
level required for differentiation; either it is of a different duration,
or of an overall different stimulation level, or happening at a
different time. Alternatively it occurs in a different subcellular
compartment from that required for differentiation [26], acting
thru Sl regulation of Spi processing (Fig. 8A, red inhibitory
interaction). This scenario also requires both the MAPK and the
insulin pathways to be active for cellular growth. Conversely, for
differentiation, reduced insulin receptor signaling leads to altered
(lower) levels of Sl activation and augmented Spi processing
(Fig. 8B, different from Fig. 8A, gray inhibitory interaction;
possibly other targets from those in Fig. 8A), and this in turn allows
MAPK activation in a manner consistent with promotion of
differentiation. This could either be caused by longer or stronger
MAPK stimulation, as documented for PC12 cells [27], since
lower Sl activity now allows higher levels of MAPK ligand
processing, and/or by compartmentalization of the activated
MAPK pathway, as shown for the Drosophila wing [26], besides
happening at different times during development. In this second
case, only the MAPK pathway is required to be fully active.
Finally, loss-of-function mutant conditions for sl lead to ectopic
differentiation at the expense of growth.
We found that genomic sl constructs carrying either a mutant
C-SH2 or N-SH2 domain rescued the wing size defect of sl
mutants, to an extent equivalent to a wild type sl construct. The
amino acid sequence of Sl is well conserved compared to
Figure 8. Sl modes of action in growth and differentiation. Panel (A) shows Sl, activated by the insulin pathway, acting as a liaison regulating
MAPK pathway ligand processing, to foster MAPK activation to a level promoting growth (red inhibitory interaction). (B) Conversely, for
differentiation, reduced insulin receptor signaling leads to lower levels of Sl activation and augmented Spi processing (different from A, gray
inhibitory interaction; possibly other targets from those in A), and this, in turn, allows MAPK activation in a manner consistent with promotion of
differentiation.
doi:10.1371/journal.pone.0028067.g008
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changed since flies and mammals diverged; if this is so, our results
imply that PIP2 hydrolysis is not required for Sl’s role regulating
cell growth. This is consistent with previous reports showing that
mitogenic activity triggered by PLC-c in mammals does not
depend on its phospholipase function [36]. In mammals, in some
contexts, this is due to an SH3-mediated interaction between PLC-
c and PIKE (PI3K enhancer) for nuclear PI3K activity [37].
Another mammalian study showed that the PLC-c PH domain is
sufficient for both membrane association and activation of
mammalian PLC-c following activation of PI3K [30]. If any of
these scenarios also occur in Drosophila, this would be consistent
and explain why the N-SH2 domain of Sl is dispensable for its role
in regulating cell growth, while providing a possible tie-in with the
PI3K activation triggered during insulin signaling.
In contrast to the results for cell growth, we found that the N-
SH2 domain is necessary for Sl to regulate proper differentiation
of R7 photoreceptors and wing veins. In mammals, the PLC-c N-
SH2 domain binds to a phosphotyrosine either on the activated
receptor or an adaptor; whereas the PLC-c1 C-SH2 domain is
thought to be necessary for activation of phospholipase activity,
binding to a phosphotyrosine within PLC-c itself, this site having
been phosphorylated before by the activated RTK after PLC-c
binding [38]. This suggests that differentiation depends on the
more traditional model of PLC-c activity, requiring binding of the
N-SH2 domain to either a receptor or an adaptor. The SH2
mutant constructs therefore confirm earlier findings that the
growth and differentiation defects seen in sl mutants are driven by
distinct and mutationally separable pathways [35].
‘‘Parental control’’ by Sl
Taken together, our results indicate that Sl participates in fine
coordination of growth and differentiation during development.
Although Sl is not essential for wing or eye growth and
development, it is necessary to achieve appropriate final structure
and size. In the absence of Sl function, these tissues arrest growth
prematurely and probably initiate differentiation earlier, resulting
in ectopic differentiation while attaining smaller cellular sizes. As
such, Sl can be seen as exerting a kind of ‘‘parental control’’ that
protects cells from differentiating before attaining a normal size.
This function requires Sl to change cellular behavior from growth
(or possibly inhibition of differentiation) to differentiation in a
short period of time.
PLC-c1 has been demonstrated to be a phosphorylation target
of MAPK [39,40], and some PKC isoforms can phosphorylate
PLC-c without affecting PIP2 hydrolysis [41] so it is clear that
there is a complex interplay of signaling among this set of
molecules following RTK activation. Further study of the
dynamics of Sl-regulated EGF/MAPK signaling in space and
time during wing and eye development in Drosophila may help to
expose more of this network.
Materials and Methods
Drosophila stocks
Flies were raised at 25uC under standard conditions. Fly stocks
used were: sl
1/FM7c and sl
2/FM7c obtained from J. Carlson (Yale
University, USA). The sl
1 allele is produced by a insertion of a 412
transposable element in the exon encoding the C-terminal end of
the split PH domain, resulting in loss of the region Y catalytic
domain as well as the C2 domain; sl
2 carries a 13 bp deletion just
before the exon encoding the N-terminal SH2 domain, resulting in
the loss of both SH2 domains, the SH3 domain, region Y and the
C2 domain. Both alleles are strong hypomorphs [35]. sl
9/FM7c was
generated in a Canton S background and characterizedby one of us
(J. Thackeray); sl
9 is a point mutation that changes a tryptophan to a
stop codon at the beginning of the open reading frame, and thus,
creates a null allele [35,42]. InR
E19/TM3, InR
GC25/TM3, InR
3T5/
TM3, chico
1/CyO, Dp110
5W3/TM6, PKB
1/TM3 and PKB
3/TM3
were obtained from E. Hafen (ETH, Switzerland); aos
D7/TM3,
Egfr
f2/CyO, Dos
R31/TM3, drk
e0A/CyO, rl
1/CyO, Ras85D
e2f/
CyO, Sos
34/CyO, Sos
dm7/CyO, Rack1
EE/CyO, rho
ve-1/TM3, S
2/
In(2LR)bw
V1ds
33K, spi
1/CyO, Ip3R
B4/TM3, PKC53E
EY14093/CyO,
vn
C221/TM3 and P{ey-FLP.N}6, ry
506 were from the Bloomington
Drosophila stock center at Indiana University, USA.
Genetics
Genetic interactions were made by crossing sl
1, sl
2,o rsl
9
homozygous virgin females with males of the following genotypes:
InR
E19/TM3, InR
GC25/TM3, chico
1/CyO, Dp110
5W3/TM6, PKB
1/
TM3, aos
D7/TM3, Egfr
f2/CyO, Dos
R31/TM3, drk
e0A/CyO, rl
1/CyO,
Ras85D
e2f/CyO, Sos
34/CyO, Sos
dm7/CyO, Rack1
EE/CyO, rho
ve-1/
TM3, S
2/In(2LR)bw
V1ds
33K, spi
1/CyO, Ip3R
B4/TM3, vn
C221/
TM3 and PKC53E
EY14093/CyO. We selected male progeny
hemizygous for sl
1, sl
2 or sl
9 and heterozygous for mutations
under study by the absence of the marked balancer chromosomes.
For rescue experiments, we likewise crossed males with the
different rescue constructs to sl
2 mutant females, and selected male
progeny hemizygous for sl
2 with the rescue construct.
Body Weight and Length Measurements
For adult body weight measurements, sibling sl
9 homozygotes
and sl
9/FM7 females were collected and aged for two days in
groups of ten in fresh vials before use. Individual cold-killed flies
were measured in a microbalance (Cahn C-31, USA) with 0.1 mg
sensitivity and a range of 0.1 mg–25 mg. n=70 flies/genotype. For
pupal measurements, we crossed sl
9 males to sl
9/FM7 females in
non-crowded conditions in fly bottles. Third instar larvae were
recovered and sexed, and females, in groups of twenty, were
housed in food vials. From these, female pupae from stages P12–
P15 [43] were used. Pupae were weighed as above. Also, and
similar to [15,16], the long axis of the pupal case was measured for
each pupae under a dissecting microscope with the aid of a
micrometer grid.
Analysis of wings
Flies were anesthetized with CO2 and wings were dissected,
placed in absolute ethanol and mounted in a mixture of lactic
acid:ethanol (6:5) [10]. Wings were examined under a compound
microscope. Measurements of wing surface and ectopic vein areas
were made manually using IPLab software. For measurements of
cellular density in wings, a small region between veins 3 and 4 was
selected, and the total number of cells within this region was
counted on one wing surface. In order to calculate cell densities,
we divided the number of cells counted by the area surveyed
(0.0298 mm
2). This measurement was validated as representative
of total wing area by counting the total number of cells in one wing
surface in a few experiments.
Scanning Electron Microscopy (SEM) of Whole Eyes
Flies were cold anesthetized, mounted and oriented sideways
unto stubs by means of carbon paint. They were then viewed with
a JEOL 1010 SEM under high vacuum conditions, with 20 KeV
accelerating voltage, and whole eyes positioned perpendicular to
the electron beam were digitized at 230x. Only one eye was
accessible per fly. Digitized images were used to measure eye area
and number of ommatidia using ImageJ.
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Histology was performed according to Riesgo-Escovar, et al.
[44]. Briefly, flies were anesthetized with CO2 and decapitated.
Heads were placed on slides and cut in half by a medial sagittal
section. The eyes were then fixed in 2% glutaraldehyde, 1% OsO4
in 1x cacodylate buffer (50 mM, pH 7.4) on ice for 30 minutes.
The eyes were post-fixed in 2% OsO4 in 1x cacodylate buffer on
ice for 2 hours. The OsO4 solution was then removed and the eyes
were dehydrated through a graded acetone series. Absolute
acetone was replaced with a mixture of Spurr’s resin:acetone
(1:1) overnight. This mixture was replaced with 100% fresh
Spurr’s for at least 4 hours to allow the resin to infiltrate the tissue.
The eyes were placed in plastic molds in 100% Spurr’s and
oriented using a fine needle. The molds were incubated at 60–
65uC for 24–70 hours. Eyes were sectioned tangentially with a
microtome (Leica RM2265) using glass knives. Sections of 1 mm
thick were obtained, placed on slides, and stained with toluidine
blue for approximately 30 seconds [45]. Finally, sections were
mounted in Entellan (Electron Microscopy Sciences) and viewed
on a compound microscope. Sections with fewer than 150
ommatidia were always selected for analysis, to assure that all
ommatidia examined were at the level of the R7 rhabdomere.
Analysis of loss-of-function clones in eyes
Patches of tissue lacking sl function were generated by the FLP-
FRT system as described [46], by subjecting 2–4 day old larvae of
genotype yws l
9 FRT19A/FRT19A;hsFLP/+ to heat shock.
Heads containing at least one w
- clone were embedded in resin,
sectioned and stained with toluidine blue as described [44,45].
Ommatidia were scored for area of the R1–R6 rhabdomeres as a
series of matched pairs from each head; each pair consisted of one
w+ ommatidium surrounded by all w+ ommatidia, and one w-
ommatidium surrounded by w- ommatidia. Each member of the
pair was separated from the other member by no more than 3
other ommatidia, so that differences that occur due to the angle of
section were minimized. The area of each rhabdomere was
determined using the wand tool within ImageJ version 1.43u
(Wayne Rasband, National Institutes of Health, Bethesda, MD).
small wing constructs
A series of constructs were prepared from a 10 kb genomic
DNA fragment (X10), that includes the entire sl transcription unit.
The X10 fragment was subcloned into pBluescript KS, reisolated
as a KpnI/NotI digest and ligated into the KpnI and NotI sites of
pCaSpeR-4. Modified versions of X10 were produced by site-
directed mutagenesis using the Quikchange kit (Stratagene). The
X10 fragment was modified in R619 to A (R619 is a critical amino
acid for the function of the N-SH2 domain) and independently in
R726 to A (R726 is a critical amino acid for the function of the C-
SH2 domain). The mutations were generated in a 1.7 kb BamH1
fragment subcloned from X10 and confirmed by sequence
analysis. The fragments were reconstructed in pBluescript and
recloned into the KpnI and NotI sites of pCaSpeR-4. The plasmids
were injected into syncytial blastoderm embryos at a final
concentration of 1 mg/ ml together with 0.1 mg/ ml D2–3 helper
plasmid in a buffer containing 0.1 mM sodium phosphate (pH 7.8)
and 5 mM KCl. The plasmids were detected by the presence of
the w
+ gene marker of pCaSpeR-4 in transformed progeny [35].
Statistical Analysis
Data are presented as mean 6 SEM. The mean values were
compared using Student’s t test.
Supporting Information
Figure S1 PKC53E mutant flies have wing phenotypes.
Homozygous mutant PKC53E
EY14093 flies are viable and fertile,
but have reduced wings (A) and ectopic wing veins (B), yet normal
numbers of R7 photoreceptors in the eye (C). Each test is
accompanied by corresponding control siblings. *p,0.001; error
bars represent SEM, n=100 for (A) and (B), and n=4 eyes for
each genotype, #150 ommatidia examined per eye.
(TIF)
Figure S2 Reduced gene dosage of signaling genes on
the sl
9 ectopic wing vein phenotype. n=100. *p,0.001;
error bars represent SEM.
(TIF)
Figure S3 aos acts as a strong enhancer of sl in the eye.
(A) Shows a scanning EM of an eye from an aos heterozyote male
fly, with normal morphology. (B) Shows a scanning EM of an eye
from a male sl
2 fly, sibling to the fly in (C) that also carries a
mutant copy of aos (aos
D7). Note slight roughness of the eye on (B),
enhanced in the eye in (C). Scale bar in (B) is 100 micrometers.
(TIF)
Figure S4 Reduced gene dosage of signaling genes on sl
1
and sl
9 extra R7 phenotypes. (A, B) show histograms with the
effects of heterozygosity for different signaling genes on the
number of ommatidia with extra R7 cells in sl
1 (A) and sl
9 (B)
mutants. n=50–100 ommatidia per eye, from 4–7 eyes. *p,0.001;
error bars represent SEM.
(TIF)
Figure S5 Homozygosity for sl
2 does not modify the
dominant S
2 R7 phenotype in the eye. Histogram showing
the average number of R7 cells per ommatidium in eyes from
heterozygous S
2 flies, or from flies also mutant for sl
2. n=5 eyes
each with #150 ommatidia per eye. Error bars represent SEM.
(TIF)
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